NCT00883506View on ClinicalTrials.gov

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

June 30, 2000

Study Completion Date

June 30, 2000

Conditions
Hypertension
Interventions
DRUG

Lisinopril 40 mg Tablet (Zestril) under fed conditions.

DRUG

Lisinopril 40 mg Tablet under fasting conditions.

DRUG

Lisinopril 40 mg Tablet under fed conditions.

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY